Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dapu Biotechnology
Jiaxing, Zhejiang, China
- Ownership
- Private
- Employees
- ~200
- Development stage
- Other
01
Overview
Dapu Biotechnology's lead CytoSpark™ droplet microfluidics platform enables ultra-high-throughput discovery of antibodies—including single-domain human antibodies—dramatically reducing time to candidate from months to days; it is deployed in antibody screening, enzyme evolution, and cancer research applications with evidence of robust functional antibody selection from complex targets[2][5][7][8][10].
- Modalities
- Monoclonal antibodyNanobody therapyAntibodySingle-domain antibody
- Industry
- Drug Discovery Services
02
Partnerships
Leveragen (antibody discovery, single-domain antibody screening)[2][14]
Beyond the preview
Go deeper on Dapu Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dapu Biotechnology.